NLRP3 inflammasome activation through caspase‐1 will trigger cardiomyocyte pyroptosis to induce dilated cardiomyopathy, which will be regarded as a proper therapeutic target of dilated cardiomyopathy. The gene discussed is NLRP3; the disease is dilated cardiomyopathy.